PMID: 8610110Apr 2, 1996Paper

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase

Proceedings of the National Academy of Sciences of the United States of America
Walter Filgueira de AzevedoS H Kim

Abstract

The central role of cyclin-dependent kinases (CDKs) in cell cycle regulation makes them a promising target for studying inhibitory molecules that can modify the degree of cell proliferation. The discovery of specific inhibitors of CDKs such as polyhydroxylated flavones has opened the way to investigation and design of antimitotic compounds. A novel flavone, (-)-cis-5,7-dihydroxyphenyl-8-[4-(3-hydroxy-1-methyl)piperidinyl] -4H-1-benzopyran-4-one hydrochloride hemihydrate (L868276), is a potent inhibitor of CDKs. A chlorinated form, flavopiridol, is currently in phase I clinical trials as a drug against breast tumors. We determined the crystal structure of a complex between CDK2 and L868276 at 2.33 angstroms resolution and refined to an Rfactor 20.3%. The aromatic portion of the inhibitor binds to the adenine-binding pocket of CDK2, and the position of the phenyl group of the inhibitor enables the inhibitor to make contacts with the enzyme not observed in the ATP complex structure. The analysis of the position of this phenyl ring not only explains the great differences of kinase inhibition among the flavonoid inhibitors but also explains the specificity of L868276 to inhibit CDK2 and CDC2.

References

Nov 18, 1992·Journal of the National Cancer Institute·G KaurE Sausville
Jan 1, 1992·Annual Review of Biochemistry·C Norbury, P Nurse
May 1, 1992·Molecular Biology of the Cell·D DesaiD O Morgan
Jul 1, 1990·Acta Crystallographica. Section A, Foundations of Crystallography·A T BrüngerJ W Erickson
Apr 1, 1989·Current Opinion in Cell Biology·T Hunt
Sep 20, 1987·Journal of Molecular Biology·S SheriffJ L Smith
Jun 15, 1994·Biochemical and Biophysical Research Communications·M D LosiewiczP J Worland
May 15, 1994·Structure·S S Taylor, E Radzio-Andzelm
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·L HengstS I Reed
Dec 16, 1993·Nature·Y XiongD Beach
Apr 20, 1993·Journal of Molecular Biology·J RosenblattS H Kim
Jun 17, 1993·Nature·H L De BondtS H Kim

❮ Previous
Next ❯

Citations

May 23, 2001·Archives of Biochemistry and Biophysics·A KaiserJ B Schnier
Aug 13, 2005·Journal of Molecular Modeling·Karisa Karla ManhaniFernanda Canduri
Dec 24, 2005·Journal of Molecular Modeling·Alfonso T García-Sosa, Ricardo L Mancera
Jan 28, 2009·Journal of Molecular Modeling·Ivani PauliWalter Filgueira de Azevedo
Dec 17, 2009·Journal of Molecular Modeling·Bing ZhangVincent B C Tan
Oct 21, 2006·Journal of Computer-aided Molecular Design·Bing ZhangTong Earn Tay
Jan 10, 2013·Cell Biochemistry and Biophysics·N Nagasundaram, C George Priya Doss
Jan 7, 2004·Biochemical and Biophysical Research Communications·Fernanda CanduriDiógenes Santiago Santos
Jun 27, 2002·Biochemical and Biophysical Research Communications·Walter Filgueira de AzevedoDiógenes Santiago Santos
Jul 20, 2002·Biochemical and Biophysical Research Communications·Cheol Hee ChoiYoun Chul Kim
Oct 10, 2002·Biochemical and Biophysical Research Communications·Walter Filgueira de AzevedoNelson José Freitas da Silveira
Mar 17, 1999·Toxicon : Official Journal of the International Society on Toxinology·W F de AzevedoR K Arni
Jan 17, 2002·Leukemia Research·Igor SemenovSeth J Corey
Aug 23, 2002·Pharmacology & Therapeutics·Doriano FabbroPaul W Manley
Aug 23, 2002·Pharmacology & Therapeutics·Thomas G DaviesMartin E M Noble
Aug 24, 1999·Pharmacology & Therapeutics·P Traxler, P Furet
Aug 24, 1999·Pharmacology & Therapeutics·J M SowadskiR Karlsson
Aug 24, 1999·Pharmacology & Therapeutics·E A SausvilleA Senderowicz
Sep 19, 2002·Trends in Pharmacological Sciences·Marie KnockaertLaurent Meijer
Apr 11, 2001·Molecular and Biochemical Parasitology·P HassanJ C Mottram
Nov 25, 2000·Journal of Ethnopharmacology·B S Shylesh, J Padikkala
Mar 11, 1999·Current Opinion in Genetics & Development·M D Garrett, A Fattaey
Jun 8, 2000·Bioorganic & Medicinal Chemistry Letters·K K MurthiK Pal
Jul 13, 2000·Bioorganic & Medicinal Chemistry Letters·D N TchamoA Di Pietro
Oct 14, 2003·Bioorganic & Medicinal Chemistry Letters·Concha Sanchez-MartinezJill Wagner
Feb 17, 1999·Bioorganic & Medicinal Chemistry Letters·P ImbachJ Zimmermann
Apr 18, 2001·Trends in Cell Biology·A C BishopK M Shokat
Apr 20, 2001·Critical Reviews in Oncology/hematology·H H Sedlacek
Jun 6, 2002·Drug Discovery Today·Giovanna Scapin
Aug 1, 1997·Current Opinion in Chemical Biology·S S Taylor, E Radzio-Andzelm
Mar 26, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Steven Grant, John D Roberts
Mar 20, 2009·Quarterly Reviews of Biophysics·Louise N Johnson
Dec 17, 2011·Journal of Chemical Information and Modeling·Wasinee KhuntaweeSupot Hannongbua

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.